Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?
González-Gascón-Y-Marín I, Muñoz-Novas C, Figueroa I, Hernández-Sánchez M, Rodríguez-Vicente AE, Quijada-Álamo M, Pérez-Carretero C, Moreno C, Collado R, Espinet B, Puiggros A, Heras NL, Bosch F, Hernández JÁ; Grupo Español de Leucemia Linfática Crónica and Grupo Cooperativo Español de Citogenética Hematológica. González-Gascón-Y-Marín I, et al. Among authors: munoz novas c. Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):548-555.e4. doi: 10.1016/j.clml.2020.03.003. Epub 2020 Apr 13. Clin Lymphoma Myeloma Leuk. 2020. PMID: 32389671
The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.
Muñoz-Novas C, Poza-Santaella M, González-Gascón Y Marín I, Hernández-Sánchez M, Rodríguez-Vicente AE, Infante MS, Heras C, Foncillas MÁ, Marín K, Hernández-Rivas JM, Hernández JÁ. Muñoz-Novas C, et al. Biomed Res Int. 2018 Mar 15;2018:9506979. doi: 10.1155/2018/9506979. eCollection 2018. Biomed Res Int. 2018. PMID: 29736400 Free PMC article.
From Biomarkers to Models in the Changing Landscape of Chronic Lymphocytic Leukemia: Evolve or Become Extinct.
González-Gascón-Y-Marín I, Muñoz-Novas C, Rodríguez-Vicente AE, Quijada-Álamo M, Hernández-Sánchez M, Pérez-Carretero C, Ramos-Ascanio V, Hernández-Rivas JÁ. González-Gascón-Y-Marín I, et al. Among authors: munoz novas c. Cancers (Basel). 2021 Apr 8;13(8):1782. doi: 10.3390/cancers13081782. Cancers (Basel). 2021. PMID: 33917885 Free PMC article. Review.
COVID-19 in patients with hematological malignancies: A retrospective case series.
Infante MS, González-Gascón Y Marín I, Muñoz-Novas C, Churruca J, Foncillas MÁ, Landete E, Marín K, Ryan P, Hernández-Rivas JÁ. Infante MS, et al. Among authors: munoz novas c. Int J Lab Hematol. 2020 Dec;42(6):e256-e259. doi: 10.1111/ijlh.13301. Epub 2020 Aug 4. Int J Lab Hematol. 2020. PMID: 32749757 Free PMC article. No abstract available.
Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine.
Landete E, Gómez-Fernández I, González-Gascón-Y-Marín I, Durán-Barquero C, Churruca J, Infante MS, Muñoz-Novas C, Foncillas MÁ, Marín K, Ramos-de-Ascanio V, Alonso-Farto JC, Hernández-Rivas JÁ. Landete E, et al. Among authors: munoz novas c. Hum Vaccin Immunother. 2021 Dec 2;17(12):5129-5132. doi: 10.1080/21645515.2021.2008215. Epub 2021 Dec 17. Hum Vaccin Immunother. 2021. PMID: 34920695 Free PMC article.
Blood transfusion activity in a general hospital during the COVID-19 pandemic.
Marín-Mori K, González-Gascón Y Marín I, Foncillas-García MÁ, Muñoz-Novas C, Infante M, Churruca-Sarasqueta J, Landete-Hernández E, Bueno-García B, Duffort-Falco M, Hernández-Rivas JÁ. Marín-Mori K, et al. Among authors: munoz novas c. Vox Sang. 2021 May;116(5):574-580. doi: 10.1111/vox.13024. Epub 2020 Nov 2. Vox Sang. 2021. PMID: 33135226
Association of Cytogenetics Aberrations and IGHV Mutations with Outcome in Chronic Lymphocytic Leukemia Patients in a Real-World Clinical Setting.
Muñoz-Novas C, González-Gascón-Y-Marín I, Figueroa I, Sánchez-Paz L, Pérez-Carretero C, Quijada-Álamo M, Rodríguez-Vicente AE, Infante MS, Foncillas MÁ, Landete E, Churruca J, Marín K, Ramos V, Sánchez Salto A, Hernández-Rivas JÁ. Muñoz-Novas C, et al. Glob Med Genet. 2024 Feb 12;11(1):59-68. doi: 10.1055/s-0044-1779668. eCollection 2024 Jan. Glob Med Genet. 2024. PMID: 38348157 Free PMC article.
Outcomes and effect of somatic mutations after erythropoiesis stimulating agents in patients with lower-risk myelodysplastic syndromes.
Caballero JC, Dávila J, López-Pavía M, Such E, Bernal T, Ramos F, Calabuig M, Hernández Sánchez JM, Pomares H, Sánchez Barba M, Abáigar M, González B, Merchán B, Sancho-Tello R, Callejas M, Muñoz-Novas C, Cerveró C, Sanz G, Hernández Rivas JM, Díez Campelo M. Caballero JC, et al. Among authors: munoz novas c. Ther Adv Hematol. 2024 Jan 4;15:20406207231218157. doi: 10.1177/20406207231218157. eCollection 2024. Ther Adv Hematol. 2024. PMID: 38186638 Free PMC article.
Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice.
Montoro MJ, Pomares H, Coll R, Bernal Del Castillo T, Tormo M, Jiménez A, Brunet S, Casaño J, Oiartzabal I, Díez-Campelo M, Ramos F, Romero R, Salido-Fiérrez E, Pedro C, Bargay J, Muñoz-Novas C, López R, Rafel M, Valcárcel D; ERASME study group. Montoro MJ, et al. Among authors: munoz novas c. Leuk Lymphoma. 2023 Mar;64(3):679-690. doi: 10.1080/10428194.2022.2154604. Epub 2022 Dec 28. Leuk Lymphoma. 2023. PMID: 36577016